Ischemic Stroke

Patients with syphilis experienced higher rates of CV events like stroke, MI and death compared with a matched control group, according to a large-scale, real-world study published in European Heart Journal.

ATLANTA — In patients with ACS who underwent PCI, ticagrelor monotherapy after 1 month lowered bleeding risk by 55% compared with dual antiplatelet therapy for 12 months, according to the results of the ULTIMATE-DAPT trial.

Nontraditional risk factors such as migraine, valvular heart disease and thrombophilia may be linked to increased risk for stroke among younger adults, researchers reported.

In a prospective cohort study, excessive exposure to outdoor artificial light at night and air pollution were associated with elevated risk for stroke, researchers reported in Stroke.

People who did not adhere to a long-term aspirin regimen after an MI had a higher risk for recurrent MI, stroke or death, although the risk appeared less pronounced among older adults and women, according to study results.

Data show one in three patients in Denmark with obesity, no diabetes and a first-time MI met eligibility criteria for the SELECT CV outcomes trial, and that one major CV event can be prevented for every 49 people who receive semaglutide.

For patients with cervical artery dissection initially treated with anticoagulation, switching to antiplatelet therapy at 30 days may prevent bleeding events later, as stroke risk was lower by then, researchers reported.

An artificial intelligence-enabled smartphone application developed to detect symptoms of stroke accurately evaluated facial asymmetry, arm weakness and speech changes in line with stroke onset, a speaker reported.

Use of assisted reproductive technology was associated with increased odds of stroke during index hospitalization for delivery, regardless of maternal age, researchers reported.

Treatment with selective serotonin/serotonin-norepinephrine reuptake inhibitors after ischemic stroke was associated with low risk of bleeding events at 1 year, according to a presenter at the International Stroke Conference.